menu
    • menu

    Company profile for Marker Therapeutics

    NEW Drugs in Dev: 8
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. We developed our lead product candidates from our MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recogniz...
    We are a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. We developed our lead product candidates from our MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Marker TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3200 Southwest Fwy #2240 Phoenix Tower Houston, TX 77027
    Telephone
    Telephone
    +1 (713) 400-6400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://markertherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/marker-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MRKRTherapeutic

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Marker Therapeutics at Oppenheimer 36th HCLS Conference
    Marker Therapeutics at Oppenheimer 36th HCLS Conference

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240173/0/en/Marker-Therapeutics-to-Present-at-the-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    GMA Spotlights Baylor's MAR-T Pancreatic Cancer Study
    GMA Spotlights Baylor's MAR-T Pancreatic Cancer Study

    26 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/26/3225492/0/en/Good-Morning-America-Features-Baylor-College-of-Medicine-Pancreatic-Cancer-Study-Utilizing-Marker-Therapeutics-MAR-T-Cell-Technology.html

    GLOBENEWSWIRE
    26 Jan 2026
    Share Share
    Baylor College Of Medicine Releases Positive Results
    Baylor College Of Medicine Releases Positive Results

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212598/0/en/Baylor-College-of-Medicine-Publishes-Promising-Safety-and-Efficacy-Results-of-Multi-Antigen-Targeted-T-Cells-in-Patients-with-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Marker Therapeutics Unveils Q3 2025 Financials & Business Result
    Marker Therapeutics Unveils Q3 2025 Financials & Business Result

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188189/0/en/Marker-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Marker Therapeutics Appoints Kathryn Penkus Corzo To Board
    Marker Therapeutics Appoints Kathryn Penkus Corzo To Board

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181360/0/en/Marker-Therapeutics-appoints-Kathryn-Penkus-Corzo-to-Board-of-Directors.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Marker Therapeutics To Present MT-601 Data For Relapsed Lymphoma
    Marker Therapeutics To Present MT-601 Data For Relapsed Lymphoma

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179422/0/en/Marker-Therapeutics-Announces-Upcoming-Presentations-on-MT-601-in-Relapsed-Non-Hodgkin-and-Hodgkin-Lymphoma-at-the-67th-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Contact Marker Therapeutics and get a quotation

    Marker Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of HER2 PEPTIDE VACCINE bulk offered by Marker Therapeutics

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search